Kotak Healthcare Fund Direct IDCW NAV today
AMFI: 152215ISIN: INF174KA1QA8MUTF_IN: KOTA_HEAL_DIR_82ZA2AKotak Mahindra Mutual FundSectoral / Thematic funds
NAV ₹16.3350
NAV for 23 Oct 2026. Declared once a day.
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month.
- ₹838 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it.
- 1.03%20 Oct 2026
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot make the fund look cheap. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted.
- 47.130 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures.
- 3530 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer.
- 12 Dec 2023
Kotak Healthcare Fund returns
Read from the direct plan's growth option: an IDCW plan's NAV falls by every payout, so it carries no return of its own
Over each window to 23 Oct 2026
| Over | ReturnTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. | Rank in categoryRank in category. The fund's place among the funds of its category with a return over the same window, highest return first. | Category medianCategory median. The middle return of the funds in the category over the same window: half returned more, half less. | Middle halfMiddle half of the category. The returns of the fund a quarter of the way down the category and the fund a quarter of the way up, over the same window: half the category's funds returned between the two. |
|---|---|---|---|---|---|
| 1 week | −3.87% | −1.89% | – | – | – |
| 1 month | −10.43% | −8.78% | 229 of 254 | −8.23% | −9.5% to −6.6% |
| 3 months | −2.96% | −5.51% | 38 of 250 | −6.23% | −7.7% to −4.3% |
| 6 months | +13.41% | +4.34% | 4 of 250 | −3.43% | −6.3% to +2.1% |
| 1 year | +14.68% | +3.18% | 8 of 228 | −5.19% | −9.3% to +0.6% |
| 3 years | Needs 3 years | – | – | +12.40% | +8.6% to +16.8% |
| 5 years | Needs 5 years | – | – | +10.89% | +8.1% to +14.6% |
| 10 years | Needs 10 years | – | – | +13.74% | +11.5% to +15.5% |
₹10,000 put in on 18 Dec 2023 is ₹16,271 at the NAV of 23 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load.Over a year and longer, a return is the yearly rate. Benchmark: NIFTY Healthcare TRI, over the same days as the fund. Rank, median and middle half among the Direct plans of Sectoral / Thematic funds, each fund's return to its latest NAV on or before 25 Oct 2026.
At the month end, 30 Sep 2026
| Over | FundTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. |
|---|---|---|
| 1 year | +29.80% | +14.70% |
| Since launch | +22.23% | +18.60% |
Benchmark: NIFTY Healthcare TRI. Both as the fund house states them for the month.
Return in each calendar year
- Fund, Direct GrowthCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- NIFTY Healthcare TRIBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer.
- Loss
Highest year to Dec 2024, +41.9%; lowest year to Dec 2025, −5.8%
Kotak Healthcare Fund SIP returns
₹10,000 on the 1st of every month, valued at the NAV of 23 Oct 2026
| Period | InvestedAmount invested. ₹10,000 on the 1st of every month, or the next day the fund priced, added up over the period. | Value todayValue today. What the units bought by every instalment are worth at the latest NAV. | Invested against value today | SIP returnSIP return (XIRR). The yearly rate that, applied to each monthly instalment from the day it was invested, gives the value of all the units today. | After stamp dutySIP return after stamp duty. The same SIP return with stamp duty of 0.005% taken from every instalment since 1 Jul 2020, so ₹10,000 buys ₹9,999.50 of units. | Stamp dutyStamp duty paid. The stamp duty on all the instalments, in rupees: 0.005% of each purchase made since 1 Jul 2020. |
|---|---|---|---|---|---|---|
| 1 year12 instalments | ₹1,20,000 | ₹1,30,301₹1,30,295 after stamp duty | +17.05% | +17.04% | ₹6 | |
| Since Dec 202334 instalments | ₹3,40,000 | ₹4,14,255₹4,14,234 after stamp duty | +14.30% | +14.29% | ₹17 |
3 years: Launched 12 Dec 2023, needs 3 years of history.
From the Direct Growth plan's NAV, since an IDCW plan's NAV falls by each payout.
Rolling returns
Per cent a year, every window from 18 Dec 2023 to 23 Oct 2026
Lowest to highestAverage
LowestLowest rolling return. The worst yearly return of any window of this length in the fund's history, one window starting on each day it priced.AverageAverage rolling return. The average of the yearly returns of every window of this length in the fund's history.HighestHighest rolling return. The best yearly return of any window of this length in the fund's history.Ended higherWindows that ended higher. The share of all the windows of this length in which the NAV ended above where it started.
1 year457 windows−6.2%+13.5%+42.3%86.2%
3 yearsLaunched 12 Dec 2023, needs 4 years of history
From the Direct Growth plan's NAV, since an IDCW plan's NAV falls by each payout.
Kotak Healthcare Fund expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- Regular over directDirect and regular plan cost gap. The regular plan's expense ratio less the direct plan's: what buying through a distributor costs each year, since both plans own the same portfolio.
- 1.52 ptsA year, on 20 Oct 2026
- Direct, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 1.04%Over the last 30 days filed
- Regular, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 2.55%Over the last 30 days filed
Total expense ratio, month by month
- Regular plan
- Direct plan
Direct plan highest 1.09%, Jul 2026.Direct plan lowest 0.70%, Feb 2024.
What the expense ratio is made of
| Part | Direct | Regular |
|---|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. | 0.72% | 2.00% |
| Brokerage | 0.04% | 0.04% |
| Transaction costs | 0.00% | 0.00% |
| Statutory levies | 0.27% | 0.51% |
Per cent of assets a year, filed for 20 Oct 2026. The parts add up to that day's total.
Exit load, in the fund house's words
For redemption / switch out within 30 days from the date of allotment: 0.5% If units are redeemed or switched out on or after 30 days from the date of allotment: NIL Units issued on reinvestment of IDCW shall not be subject to entry and exit load. Any exit load charged (net off Goods and Services tax, if any) shall be credited back to the Scheme.MoreLess
Buying and selling
- Lump-sum purchases
- Accepted
- Minimum investmentMinimum investment. The smallest amount the plan accepts for a first purchase.
- ₹100
- Minimum top-up
- ₹100
- Minimum redemption
- ₹1,000
- SIP
- Accepted
- SIP minimum
- Rs. 100/- and any amount thereafter
- SIP dates
- Any date from 1st to 31st
- STP, transfers to another fund
- Not accepted
- SWP, regular withdrawals
- Accepted
- Switches
- Accepted
- Lock-inLock-in. The time after each purchase during which those units cannot be sold.
- None
As listed for this plan on 24 Oct 2026.
Kotak Healthcare Fund AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹743 CrQuarter to Sep 2026
- In the direct plansShare of assets in the direct plans. The direct plans' average assets for the quarter as a percentage of the fund's total; the rest is in the regular plans, bought through distributors.
- 15.2%Of the quarter's average
Average assets by quarter, by plan
- Regular plans
- Direct plans
The latest quarter is the largest since the quarter to Dec 2023.
Assets at each month end
The latest month end is the highest since Dec 2024.Lowest ₹380 Cr, Feb 2025.
Kotak Healthcare Fund portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. | |||
|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals and Biotechnology | Large cap13th | 13.21% | 109.00 | 6,00,000 | Dec 2023or earlier |
| Divi's LaboratoriesPharmaceuticals and Biotechnology | Large cap50th | 9.35% | 77.12 | 83,000 | Dec 2023or earlier |
| Molbio DiagnosticsHealthcare Equipment and Supplies | 5.08% | 41.88 | 3,20,000 | Aug 2026 | |
| Torrent PharmaceuticalsPharmaceuticals and Biotechnology | Large cap61st | 4.65% | 38.40 | 80,000 | Jul 2026 |
| Acutaas ChemicalsPharmaceuticals and Biotechnology | Small cap347th | 4.17% | 34.43 | 1,05,000 | May 2024 |
| Max Healthcare InstituteHealthcare Services | Mid cap111th | 3.61% | 29.75 | 3,20,000 | Dec 2023or earlier |
| CiplaPharmaceuticals and Biotechnology | Large cap99th | 3.26% | 26.92 | 2,00,000 | Dec 2023or earlier |
| Park Medi WorldHealthcare Services | Small cap578th | 3.17% | 26.12 | 9,50,000 | Dec 2025 |
| Gland PharmaPharmaceuticals and Biotechnology | Small cap261st | 3.16% | 26.09 | 90,000 | May 2025 |
| Yatharth Hospital & Trauma Care ServicesHealthcare Services | Small cap672nd | 3.12% | 25.71 | 2,49,000 | Dec 2024 |
| Apollo Hospitals EnterpriseHealthcare Services | Large cap97th | 2.97% | 24.50 | 30,000 | Dec 2023or earlier |
| Sai Life SciencesPharmaceuticals and Biotechnology | Small cap329th | 2.96% | 24.39 | 1,60,000 | Dec 2024 |
| Laurus LabsPharmaceuticals and Biotechnology | Mid cap171st | 2.88% | 23.76 | 1,20,000 | May 2026 |
| Mankind PharmaPharmaceuticals and Biotechnology | Mid cap119th | 2.73% | 22.53 | 90,000 | Jan 2025 |
| Krishna Institute of Medical SciencesHealthcare Services | Small cap285th | 2.71% | 22.39 | 3,00,000 | Dec 2023or earlier |
Weight is per cent of the fund's net assets; value in ₹ crore.
Cash and receivables on 30 Sep 2026
| Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | ||
|---|---|---|
| Triparty Repo | 3.01% | 24.80 |
| Net Current Assets/(Liabilities) | −1.70% | −14.09 |
Weight is per cent of the fund's net assets; value in ₹ crore.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions.
- 13.21%Sun Pharmaceutical Industries
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions.
- 36.46%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions.
- 52.78%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights.
- 20.5Taken over 98.69% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought.- Indian shares98.69%
- Cash and receivables1.31%
Per cent of the fund's net assets.
Large, mid and small cap
Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month.- Large cap33.88%Category 49.50%
- Mid cap19.88%Category 21.62%
- Small cap38.82%Category 26.68%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026. Shares not on the list: 7.32% of the fund. Category is the average of 249 Sectoral / Thematic funds.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets.2sectors
- Healthcare95.10%Category 12.70%
- Chemicals3.59%Category 1.97%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026. Category is the average of 254 Sectoral / Thematic funds. Category average. The sector's weight, less the futures sold on it, averaged over the 254 Sectoral / Thematic funds that disclosed a portfolio for Sep 2026. A fund holding none of the sector counts as 0.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare33 companies | 95.10% | 98.17% | 96.90% | 98.80% | 98.65% | 98.79% | 99.13% | 98.48% | 97.96% | 96.25% | 99.03% | 98.71% | |
| Chemicals2 companies | 3.59% | 1.49% | 1.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Financial Services | 0.00% | 0.00% | 0.00% | 0.18% | 0.22% | 0.23% | 0.22% | 0.25% | 0.29% | 0.00% | 0.00% | 0.00% | |
| Capital Goods | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Automobile And Auto Components | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Consumer Services | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Information Technology | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Fast Moving Consumer Goods | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Consumer Durables | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Oil Gas & Consumable Fuels | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Telecommunication | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Power | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before.
- 12.24% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date.
- 10.17% of the fund before
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth.
- 15
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth.
- 0
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price.
- 19
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month.
- 0.17%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it.
- 5.67%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. | ||||
|---|---|---|---|---|---|
| Prasol Chemicals | New | 2.24% | 0.00% | +2.24 pts | +2,20,250 |
| Sun Pharmaceutical Industries | Added | 13.21% | 13.96% | −0.75 pts | +60,000 |
| Laurus Labs | Added | 2.88% | 2.49% | +0.39 pts | +20,000 |
| Innova Captab | Added | 1.41% | 1.08% | +0.33 pts | +23,000 |
| Viyash Scientific | Added | 1.71% | 2.01% | −0.30 pts | +15,000 |
| Apollo Hospitals Enterprise | Added | 2.97% | 3.25% | −0.28 pts | +2,000 |
| Acutaas Chemicals | Added | 4.17% | 3.91% | +0.26 pts | +10,000 |
| Krishna Institute of Medical Sciences | Added | 2.71% | 2.46% | +0.25 pts | +50,000 |
| Emcure Pharmaceuticals | Added | 1.77% | 1.57% | +0.20 pts | +10,000 |
| Park Medi World | Added | 3.17% | 3.36% | −0.19 pts | +50,000 |
| Laxmi Dental | Sold out | – | 0.17% | −0.17 pts | −65,186 |
| Aurobindo Pharma | Added | 1.72% | 1.57% | +0.15 pts | +15,000 |
| Gland Pharma | Added | 3.16% | 3.04% | +0.12 pts | +9,000 |
| Divi's Laboratories | Added | 9.35% | 9.25% | +0.10 pts | +8,000 |
| Torrent Pharmaceuticals | Added | 4.65% | 4.75% | −0.10 pts | +8,000 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries | 13.36% | 14.44% | 12.86%Cut | 12.37% | 12.53% | 13.91% | 14.04%Added | 13.01%Added | 13.73%Added | 14.88%Added | 13.96%Added | 13.21%Added |
 Divi's Laboratories | 5.60% | 5.38% | 5.46% | 6.03%Added | 5.94% | 6.05% | 5.90% | 5.95%Added | 5.33%Added | 8.26%Added | 9.25%Added | 9.35%Added |
 Molbio Diagnostics | – | – | – | – | – | – | – | – | – | – | 4.53%Bought | 5.08% |
 Torrent Pharmaceuticals | – | – | – | – | – | – | – | – | – | 6.16%Bought again | 4.75%Cut | 4.65%Added |
 Acutaas Chemicals | 3.23% | 3.43% | 3.28% | 3.81% | 4.00% | 5.09%Cut | 4.60% | 4.92% | 5.20%Added | 4.32%Cut | 3.91% | 4.17%Added |
 Max Healthcare Institute | 7.75%Added | 7.84% | 7.26% | 6.89% | 7.31% | 6.96%Cut | 6.31%Cut | 5.43% | 5.99%Added | 5.15%Cut | 4.34% | 3.61% |
 Cipla | 4.68%Cut | 4.77% | 4.84% | 4.40% | 4.17% | 3.32%Cut | 4.22%Added | 5.00%Added | 4.32% | 4.32% | 3.67% | 3.26% |
 Park Medi World | – | – | 2.54%Bought | 2.76% | 3.23% | 3.48% | 3.79%Added | 4.20% | 3.97%Added | 3.86% | 3.36% | 3.17%Added |
 Gland Pharma | 2.81% | 2.56% | 2.53%Cut | 2.81% | 2.58% | 2.11%Cut | 1.76%Cut | 2.01% | 2.21%Added | 2.75%Added | 3.04%Added | 3.16%Added |
 Yatharth Hospital & Trauma Care Services | 1.49% | 1.32% | 1.31% | 1.17% | 1.32% | 1.26% | 1.49% | 1.28% | 3.15%Added | 2.99% | 3.25% | 3.12% |
 Apollo Hospitals Enterprise | 4.23% | 4.03% | 3.99% | 3.08%Cut | 3.22% | 3.35% | 3.08% | 2.92% | 2.56% | 2.63% | 3.25%Added | 2.97%Added |
 Sai Life Sciences | 2.77%Added | 2.66% | 2.81% | 2.68% | 2.98% | 3.08%Cut | 3.02% | 2.90% | 2.91%Added | 3.08% | 3.04% | 2.96% |
 Laurus Labs | – | – | – | – | – | – | – | 1.95%Bought again | 2.24%Added | 2.66% | 2.49% | 2.88%Added |
 Mankind Pharma | 2.48% | 2.34% | 1.88%Cut | 1.88% | 1.85% | 1.72%Cut | 2.72%Added | 3.18%Added | 3.38%Added | 3.26% | 2.84% | 2.73% |
 Krishna Institute of Medical Sciences | 3.00% | 2.84% | 2.60% | 2.68% | 3.07% | 2.81% | 3.56%Added | 3.12%Cut | 3.09%Added | 2.95%Cut | 2.46% | 2.71%Added |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it.
Highest 39.6% in Apr 2025
Risk ratios
NAV to 23 Oct 2026
Each bar runs from the lowest to the highest figure among the Direct plans of Sectoral / Thematic funds (227 funds) over the same 1 year; the tick is their average and the dot this fund.
How much the NAV moves
Standard deviationStandard deviation. How far the fund's monthly returns spread around their average, stated as a yearly figure: the wider the spread, the more the NAV moves.15.70%
12.44%Lowest20.07%Average46.96%Highest
Downside deviationDownside deviation. Standard deviation counting only the months in which the fund lost money, stated as a yearly figure.6.85%
4.39%Lowest13.32%Average21.46%Highest
Sharpe ratioSharpe ratio. The monthly return above the 91-day Treasury bill yield, divided by its standard deviation and stated for a year: the extra return for each unit of movement in the NAV.1.42
−1.29Lowest0.07Average1.84Highest
Sortino ratioSortino ratio. The monthly return above the 91-day Treasury bill yield, divided by how far it fell below that yield and stated for a year: the extra return for each unit of movement on the way down.2.88
−1.42Lowest0.20Average4.31Highest
From the Direct Growth plan's NAV, since an IDCW plan's NAV falls by each payout.
Against NIFTY Healthcare TRI
BetaBeta. How much the fund's monthly return moved for each 1% move in its benchmark: 1 moves with it, below 1 moves less.0.98
0.55Lowest0.97Average of 218 funds1.47Highest
AlphaAlpha. The yearly return the fund made beyond what its beta to the benchmark accounts for.+15.29 pts
−12.14 ptsLowest+6.00 ptsAverage of 164 funds+31.48 ptsHighest
R-squaredR-squared. The share of the fund's monthly movement that its benchmark's movement explains, from 0 to 100.88.1
27.0Lowest89.5Average of 218 funds99.3Highest
CorrelationCorrelation. How closely the fund's monthly returns moved in step with its benchmark's, from minus 1 (always opposite) to 1 (always together).0.94
0.52Lowest0.94Average of 218 funds1.00Highest
Upside captureUpside capture. The fund's return in the months its benchmark rose, as a percentage of the benchmark's return in those months.126.1%
59.0%Lowest107.5%Average of 185 funds182.4%Highest
Downside captureDownside capture. The fund's return in the months its benchmark fell, as a percentage of the benchmark's fall in those months.Needs 6 falling months
Information ratioInformation ratio. The fund's return above its benchmark, divided by how much that difference varied, as stated by the fund house.To 30 Sep 20262.14
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. |
|---|---|---|---|---|
| 1 year | −10.43% | 23 Sep 2026 | 23 Oct 2026 | Not yet |
| Since Dec 2023 | −18.05% | 2 Jan 2025 | 3 Mar 2025 | 4 May 2026 |
Risk level by month
| Months | FundRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. |
|---|---|---|
| Mar 2025 to Aug 202618 months | Very High | Very HighNIFTY Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Kotak Healthcare Fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. | ||
|---|---|---|---|---|---|---|---|---|
| Dhananjay TikarihaFund Manager is the Co-Fund Manager for equity investments of the scheme. | Dec 2023 | +20.44%a year | +16.51% | +3.92 pts | – | – | 1 | ₹838 Cr |
| Abhishek BisenFund Manager is the Fund Manager for debt investment of the Scheme. | – | – | – | – | – | 85 | ₹1,87,877 Cr₹22,422 Cr alone |
Returns are the direct plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | ||
|---|---|---|---|---|---|
| Kotak Multi Cap FundAbhishek Bisen | Sep 2021 | +15.79%a year | +10.84% | +4.95 pts | ₹30,274 Cr |
| Kotak Balanced Advantage FundAbhishek Bisen | Aug 2018 | +10.45%a year | – | – | ₹16,608 Cr |
| Kotak Multi Asset Allocation FundAbhishek Bisen | Sep 2023 | +16.70%a year | – | – | ₹15,191 Cr |
| Kotak Gold ETFAbhishek Bisen | Apr 2008 | – | – | – | ₹14,402 Cr |
| Kotak Short Term FundAbhishek Bisen | Nov 2022 | +7.28%a year | – | – | ₹14,259 Cr |
| Kotak Equity Savings FundAbhishek Bisen | Sep 2014 | – | – | – | ₹10,423 Cr |
| Kotak Aggressive Hybrid FundAbhishek Bisen | Apr 2008 | – | – | – | ₹9,061 Cr |
| Kotak Income Plus Arbitrage Omni FOFAbhishek Bisen | Nov 2022 | +7.46%a year | – | – | ₹7,884 Cr |
| Kotak Gold FundAbhishek Bisen | Mar 2011 | – | – | – | ₹6,927 Cr |
| Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index FundAbhishek Bisen | Feb 2022 | +6.30%a year | +6.61% | −0.31 pts | ₹6,139 Cr |
Up to ten funds a manager, largest first. Returns are the direct plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. | Shared holdings. The number of securities both funds hold, cash and futures left out. | |
|---|---|---|
| SBI Healthcare Opportunities FundSBI Mutual Fund | 62.16% | 20 |
| Mirae Asset Healthcare FundMirae Asset Mutual Fund | 54.37% | 17 |
| ITI Pharma and Healthcare FundITI Mutual Fund | 53.03% | 17 |
| WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital Mutual Fund | 53.02% | 23 |
| PGIM India Healthcare FundPGIM India Mutual Fund | 51.27% | 18 |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | 51.06% | 18 |
| Nippon India Pharma FundNippon India Mutual Fund | 46.73% | 17 |
| Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas Mutual Fund | 45.74% | 17 |
| Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Mutual Fund | 45.68% | 20 |
| Bajaj Finserv Healthcare FundBajaj Finserv Mutual Fund | 44.79% | 15 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Overlap with the fund house's other funds
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. | |
|---|---|
| Kotak Consumption FundKotak Mahindra Mutual Fund | 19.31% |
| Kotak MNC FundKotak Mahindra Mutual Fund | 18.93% |
| Kotak Quant FundKotak Mahindra Mutual Fund | 15.21% |
| Kotak Special Opportunities FundKotak Mahindra Mutual Fund | 14.21% |
| Kotak Manufacture in India FundKotak Mahindra Mutual Fund | 12.77% |
| Kotak Dividend Yield FundKotak Mahindra Mutual Fund | 10.21% |
| Kotak Contra FundKotak Mahindra Mutual Fund | 9.84% |
| Kotak Mid Cap FundKotak Mahindra Mutual Fund | 9.45% |
| Kotak Focused FundKotak Mahindra Mutual Fund | 9.04% |
| Kotak ELSS Tax Saver FundKotak Mahindra Mutual Fund | 8.70% |
As the fund house states it, for Sep 2026.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Asset allocation
- Investments Indicative Allocation Equity and Equity Related Instruments of companies engaged in Pharma, healthcare & allied sectors - 80%-100%
- Other Equity and Equity Related Instruments of companies -0%-20%
- Debt and Money Market Instruments - 0%-20%
- Units of Gold/Silver ETF - 0-20%
- Units of InvITs - 0%-10%
Type of scheme
An open ended equity scheme investing in Pharma, Healthcare & allied sectors.
- Stated category
- Sectoral Fund
- BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back.
- Nifty Healthcare Index (Total Return Index)
- Risk level at launchRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very High
- New fund offer
- 20 Nov 2023 to 4 Dec 2023
- Units first allotted
- 12 Dec 2023
- Open for sale again
- 18 Dec 2023
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹5,000
Plans and codes
| Plan | AMFI code | ISIN | ISIN, reinvestment | MUTF_IN | First NAV |
|---|---|---|---|---|---|
| Direct Growth | 152214 | INF174KA1PZ7 | KOTA_HEAL_DIR_MULGYY | 18 Dec 2023 | |
| Regular Growth | 152216 | INF174KA1PW4 | KOTA_HEAL_REG_1M37XQ | 18 Dec 2023 | |
| Direct IDCW | 152215 | INF174KA1QA8 | INF174KA1QB6 | KOTA_HEAL_DIR_82ZA2A | 18 Dec 2023 |
| Regular IDCW | 152213 | INF174KA1PX2 | INF174KA1PY0 | KOTA_HEAL_REG_8UTX0Z | 18 Dec 2023 |
This fund
- Scheme information document (opens in a new tab)The fund's objective, terms, costs and risks in full
Factsheet
- Factsheet for September 2026 (opens in a new tab)Kotak Mahindra Mutual Fund, Sep 2026
Statement of additional information
- SAI Kotak Mahindra Mutual Fund (opens in a new tab)Kotak Mahindra Mutual Fund, Oct 2026
Annual report
- Annual Report FY 2025-26 (opens in a new tab)Kotak Mahindra Mutual Fund, Mar 2026
- Abridged Annual Report for FY 2025-26 (opens in a new tab)Kotak Mahindra Mutual Fund, Mar 2026
- KMTC Annual Report for FY 2025-26 (opens in a new tab)Kotak Mahindra Mutual Fund, Mar 2026
Riskometer disclosure
- Riskometer Disclosure as on March 2026 (opens in a new tab)Kotak Mahindra Mutual Fund, Mar 2026
Portfolio overlap disclosure
- Portfolio Overlap - September 2026 (opens in a new tab)Kotak Mahindra Mutual Fund, Sep 2026